抗血管内皮増殖因子（抗VEGF）薬市場は、製薬業界の重要なセグメントであり、特定のがんや眼疾患など、血管の異常な増殖を特徴とする疾患の治療薬を提供しています。抗VEGF薬は、血管新生を促進するタンパク質であるVEGFを標的とし、大腸がんや肺がんなどのがんにおける腫瘍の増殖を抑制し、加齢黄斑変性症（AMD）や糖尿病網膜症などの網膜疾患を治療します。この市場は、高いイノベーション、多額の研究開発投資、そして大型新薬の特許切れに伴うバイオシミラーへの移行を特徴としています。2025年までに、世界の抗VEGF薬市場は150億米ドルから250億米ドルに達すると推定され、2030年までの年平均成長率（CAGR）は2.1%から4.1%と予測されています。成長の原動力は、疾患罹患率の上昇、人口の高齢化、そしてバイオシミラーの普及ですが、特許満了と価格圧力によってその成長は抑制されています。抗VEGF薬には、モノクローナル抗体（例：ベバシズマブ、ラニビズマブ）、融合タンパク質（例：アフリベルセプト）、低分子化合物（例：スニチニブ、ソラフェニブ）があり、いずれもVEGFの活性を阻害するように設計されています。これらの薬は、がんや眼疾患の治療に不可欠であり、大きな臨床的利益をもたらす標的療法を提供します。この業界は、生物製剤の高コスト、複雑な製造プロセス、そしてロシュ社のアバスチン（ベバシズマブ）やバイエル/リジェネロン社のアイリーア（アフリベルセプト）などの特許満了に伴うバイオシミラーの出現によって形成されています。市場はまた、眼内インプラントなどの薬物送達技術の進歩や、有効性を高めるための併用療法の普及にも影響を受けています。規制当局の承認、償還ポリシー、バイオシミラーとの競争は、市場の動向を形作る重要な要因です。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Anti-VEGF Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Anti-VEGF Drugs Market in North America (2020-2030)
8.1 Anti-VEGF Drugs Market Size
8.2 Anti-VEGF Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Anti-VEGF Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Anti-VEGF Drugs Market in South America (2020-2030)
9.1 Anti-VEGF Drugs Market Size
9.2 Anti-VEGF Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Anti-VEGF Drugs Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
Chapter 10 Historical and Forecast Anti-VEGF Drugs Market in Asia & Pacific (2020-2030)
10.1 Anti-VEGF Drugs Market Size
10.2 Anti-VEGF Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Anti-VEGF Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Anti-VEGF Drugs Market in Europe (2020-2030)
11.1 Anti-VEGF Drugs Market Size
11.2 Anti-VEGF Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Anti-VEGF Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Anti-VEGF Drugs Market in MEA (2020-2030)
12.1 Anti-VEGF Drugs Market Size
12.2 Anti-VEGF Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Anti-VEGF Drugs Market Size by Type
Chapter 13 Summary For Global Anti-VEGF Drugs Market (2020-2025)
13.1 Anti-VEGF Drugs Market Size
13.2 Anti-VEGF Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Anti-VEGF Drugs Market Size by Type
Chapter 14 Global Anti-VEGF Drugs Market Forecast (2025-2030)
14.1 Anti-VEGF Drugs Market Size Forecast
14.2 Anti-VEGF Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Anti-VEGF Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Bayer
15.1.1 Company Profile
15.1.2 Main Business and Anti-VEGF Drugs Information
15.1.3 SWOT Analysis of Bayer
15.1.4 Bayer Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.2 Regeneron Pharmaceuticals
15.2.1 Company Profile
15.2.2 Main Business and Anti-VEGF Drugs Information
15.2.3 SWOT Analysis of Regeneron Pharmaceuticals
15.2.4 Regeneron Pharmaceuticals Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.3 Roche
15.3.1 Company Profile
15.3.2 Main Business and Anti-VEGF Drugs Information
15.3.3 SWOT Analysis of Roche
15.3.4 Roche Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.4 Pfizer
15.4.1 Company Profile
15.4.2 Main Business and Anti-VEGF Drugs Information
15.4.3 SWOT Analysis of Pfizer
15.4.4 Pfizer Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.5 Amgen
15.5.1 Company Profile
15.5.2 Main Business and Anti-VEGF Drugs Information
15.5.3 SWOT Analysis of Amgen
15.5.4 Amgen Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.6 Novartis
15.6.1 Company Profile
15.6.2 Main Business and Anti-VEGF Drugs Information
15.6.3 SWOT Analysis of Novartis
15.6.4 Novartis Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.7 AbbVie
15.7.1 Company Profile
15.7.2 Main Business and Anti-VEGF Drugs Information
15.7.3 SWOT Analysis of AbbVie
15.7.4 AbbVie Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.8 Samsung Bioepis
15.8.1 Company Profile
15.8.2 Main Business and Anti-VEGF Drugs Information
15.8.3 SWOT Analysis of Samsung Bioepis
15.8.4 Samsung Bioepis Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.9 Biogen Inc.
15.9.1 Company Profile
15.9.2 Main Business and Anti-VEGF Drugs Information
15.9.3 SWOT Analysis of Biogen Inc.
15.9.4 Biogen Inc. Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.10 Viatris
15.10.1 Company Profile
15.10.2 Main Business and Anti-VEGF Drugs Information
15.10.3 SWOT Analysis of Viatris
15.10.4 Viatris Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.11 Teva Pharmaceuticals
15.11.1 Company Profile
15.11.2 Main Business and Anti-VEGF Drugs Information
15.11.3 SWOT Analysis of Teva Pharmaceuticals
15.11.4 Teva Pharmaceuticals Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.12 Dr. Reddy's
15.12.1 Company Profile
15.12.2 Main Business and Anti-VEGF Drugs Information
15.12.3 SWOT Analysis of Dr. Reddy's
15.12.4 Dr. Reddy's Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.13 Xbrane Biopharma AB
15.13.1 Company Profile
15.13.2 Main Business and Anti-VEGF Drugs Information
15.13.3 SWOT Analysis of Xbrane Biopharma AB
15.13.4 Xbrane Biopharma AB Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.14 STADA Arzneimittel AG
15.14.1 Company Profile
15.14.2 Main Business and Anti-VEGF Drugs Information
15.14.3 SWOT Analysis of STADA Arzneimittel AG
15.14.4 STADA Arzneimittel AG Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.15 Formycon AG
15.15.1 Company Profile
15.15.2 Main Business and Anti-VEGF Drugs Information
15.15.3 SWOT Analysis of Formycon AG
15.15.4 Formycon AG Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.16 Bioeq AG
15.16.1 Company Profile
15.16.2 Main Business and Anti-VEGF Drugs Information
15.16.3 SWOT Analysis of Bioeq AG
15.16.4 Bioeq AG Anti-VEGF Drugs Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Anti-VEGF Drugs Report
Table Data Sources of Anti-VEGF Drugs Report
Table Major Assumptions of Anti-VEGF Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Anti-VEGF Drugs Picture
Table Anti-VEGF Drugs Classification
Table Anti-VEGF Drugs Applications
Table Drivers of Anti-VEGF Drugs Market
Table Restraints of Anti-VEGF Drugs Market
Table Opportunities of Anti-VEGF Drugs Market
Table Threats of Anti-VEGF Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Anti-VEGF Drugs
Table Cost Structure Analysis of Anti-VEGF Drugs
Table Key End Users
Table Latest News of Anti-VEGF Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Anti-VEGF Drugs Market
Table Policy of Anti-VEGF Drugs Market
Table 2020-2030 North America Anti-VEGF Drugs Market Size
Figure 2020-2030 North America Anti-VEGF Drugs Market Size and CAGR
Table 2020-2030 North America Anti-VEGF Drugs Market Size by Application
Table 2020-2025 North America Anti-VEGF Drugs Key Players Revenue
Table 2020-2025 North America Anti-VEGF Drugs Key Players Market Share
Table 2020-2030 North America Anti-VEGF Drugs Market Size by Type
Table 2020-2030 United States Anti-VEGF Drugs Market Size
Table 2020-2030 Canada Anti-VEGF Drugs Market Size
Table 2020-2030 Mexico Anti-VEGF Drugs Market Size
Table 2020-2030 South America Anti-VEGF Drugs Market Size
Figure 2020-2030 South America Anti-VEGF Drugs Market Size and CAGR
Table 2020-2030 South America Anti-VEGF Drugs Market Size by Application
Table 2020-2025 South America Anti-VEGF Drugs Key Players Revenue
Table 2020-2025 South America Anti-VEGF Drugs Key Players Market Share
Table 2020-2030 South America Anti-VEGF Drugs Market Size by Type
Table 2020-2030 Brazil Anti-VEGF Drugs Market Size
Table 2020-2030 Argentina Anti-VEGF Drugs Market Size
Table 2020-2030 Asia & Pacific Anti-VEGF Drugs Market Size
Figure 2020-2030 Asia & Pacific Anti-VEGF Drugs Market Size and CAGR
Table 2020-2030 Asia & Pacific Anti-VEGF Drugs Market Size by Application
Table 2020-2025 Asia & Pacific Anti-VEGF Drugs Key Players Revenue
Table 2020-2025 Asia & Pacific Anti-VEGF Drugs Key Players Market Share
Table 2020-2030 Asia & Pacific Anti-VEGF Drugs Market Size by Type
Table 2020-2030 China Anti-VEGF Drugs Market Size
Table 2020-2030 India Anti-VEGF Drugs Market Size
Table 2020-2030 Japan Anti-VEGF Drugs Market Size
Table 2020-2030 South Korea Anti-VEGF Drugs Market Size
Table 2020-2030 Southeast Asia Anti-VEGF Drugs Market Size
Table 2020-2030 Australia Anti-VEGF Drugs Market Size
Table 2020-2030 Europe Anti-VEGF Drugs Market Size
Figure 2020-2030 Europe Anti-VEGF Drugs Market Size and CAGR
Table 2020-2030 Europe Anti-VEGF Drugs Market Size by Application
Table 2020-2025 Europe Anti-VEGF Drugs Key Players Revenue
Table 2020-2025 Europe Anti-VEGF Drugs Key Players Market Share
Table 2020-2030 Europe Anti-VEGF Drugs Market Size by Type
Table 2020-2030 Germany Anti-VEGF Drugs Market Size
Table 2020-2030 France Anti-VEGF Drugs Market Size
Table 2020-2030 United Kingdom Anti-VEGF Drugs Market Size
Table 2020-2030 Italy Anti-VEGF Drugs Market Size
Table 2020-2030 Spain Anti-VEGF Drugs Market Size
Table 2020-2030 Belgium Anti-VEGF Drugs Market Size
Table 2020-2030 Netherlands Anti-VEGF Drugs Market Size
Table 2020-2030 Austria Anti-VEGF Drugs Market Size
Table 2020-2030 Poland Anti-VEGF Drugs Market Size
Table 2020-2030 Russia Anti-VEGF Drugs Market Size
Table 2020-2030 MEA Anti-VEGF Drugs Market Size
Figure 2020-2030 MEA Anti-VEGF Drugs Market Size and CAGR
Table 2020-2030 MEA Anti-VEGF Drugs Market Size by Application
Table 2020-2025 MEA Anti-VEGF Drugs Key Players Revenue
Table 2020-2025 MEA Anti-VEGF Drugs Key Players Market Share
Table 2020-2030 MEA Anti-VEGF Drugs Market Size by Type
Table 2020-2025 Global Anti-VEGF Drugs Market Size by Region
Table 2020-2025 Global Anti-VEGF Drugs Market Size Share by Region
Table 2020-2025 Global Anti-VEGF Drugs Market Size by Application
Table 2020-2025 Global Anti-VEGF Drugs Market Share by Application
Table 2020-2025 Global Anti-VEGF Drugs Key Vendors Revenue
Figure 2020-2025 Global Anti-VEGF Drugs Market Size and Growth Rate
Table 2020-2025 Global Anti-VEGF Drugs Key Vendors Market Share
Table 2020-2025 Global Anti-VEGF Drugs Market Size by Type
Table 2020-2025 Global Anti-VEGF Drugs Market Share by Type
Table 2025-2030 Global Anti-VEGF Drugs Market Size by Region
Table 2025-2030 Global Anti-VEGF Drugs Market Size Share by Region
Table 2025-2030 Global Anti-VEGF Drugs Market Size by Application
Table 2025-2030 Global Anti-VEGF Drugs Market Share by Application
Table 2025-2030 Global Anti-VEGF Drugs Key Vendors Revenue
Figure 2025-2030 Global Anti-VEGF Drugs Market Size and Growth Rate
Table 2025-2030 Global Anti-VEGF Drugs Key Vendors Market Share
Table 2025-2030 Global Anti-VEGF Drugs Market Size by Type
Table 2025-2030 Anti-VEGF Drugs Global Market Share by Type
Table Bayer Information
Table SWOT Analysis of Bayer
Table 2020-2025 Bayer Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Bayer Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Bayer Anti-VEGF Drugs Market Share
Table Regeneron Pharmaceuticals Information
Table SWOT Analysis of Regeneron Pharmaceuticals
Table 2020-2025 Regeneron Pharmaceuticals Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Regeneron Pharmaceuticals Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Regeneron Pharmaceuticals Anti-VEGF Drugs Market Share
Table Roche Information
Table SWOT Analysis of Roche
Table 2020-2025 Roche Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Roche Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Roche Anti-VEGF Drugs Market Share
Table Pfizer Information
Table SWOT Analysis of Pfizer
Table 2020-2025 Pfizer Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Pfizer Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Pfizer Anti-VEGF Drugs Market Share
Table Amgen Information
Table SWOT Analysis of Amgen
Table 2020-2025 Amgen Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Amgen Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Amgen Anti-VEGF Drugs Market Share
Table Novartis Information
Table SWOT Analysis of Novartis
Table 2020-2025 Novartis Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Novartis Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Novartis Anti-VEGF Drugs Market Share
Table AbbVie Information
Table SWOT Analysis of AbbVie
Table 2020-2025 AbbVie Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 AbbVie Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 AbbVie Anti-VEGF Drugs Market Share
Table Samsung Bioepis Information
Table SWOT Analysis of Samsung Bioepis
Table 2020-2025 Samsung Bioepis Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Samsung Bioepis Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Samsung Bioepis Anti-VEGF Drugs Market Share
Table Biogen Inc. Information
Table SWOT Analysis of Biogen Inc.
Table 2020-2025 Biogen Inc. Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Biogen Inc. Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Biogen Inc. Anti-VEGF Drugs Market Share
Table Viatris Information
Table SWOT Analysis of Viatris
Table 2020-2025 Viatris Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Viatris Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Viatris Anti-VEGF Drugs Market Share
Table Teva Pharmaceuticals Information
Table SWOT Analysis of Teva Pharmaceuticals
Table 2020-2025 Teva Pharmaceuticals Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Teva Pharmaceuticals Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Teva Pharmaceuticals Anti-VEGF Drugs Market Share
Table Dr. Reddy's Information
Table SWOT Analysis of Dr. Reddy's
Table 2020-2025 Dr. Reddy's Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Dr. Reddy's Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Dr. Reddy's Anti-VEGF Drugs Market Share
Table Xbrane Biopharma AB Information
Table SWOT Analysis of Xbrane Biopharma AB
Table 2020-2025 Xbrane Biopharma AB Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Xbrane Biopharma AB Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Xbrane Biopharma AB Anti-VEGF Drugs Market Share
Table STADA Arzneimittel AG Information
Table SWOT Analysis of STADA Arzneimittel AG
Table 2020-2025 STADA Arzneimittel AG Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 STADA Arzneimittel AG Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 STADA Arzneimittel AG Anti-VEGF Drugs Market Share
Table Formycon AG Information
Table SWOT Analysis of Formycon AG
Table 2020-2025 Formycon AG Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Formycon AG Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Formycon AG Anti-VEGF Drugs Market Share
Table Bioeq AG Information
Table SWOT Analysis of Bioeq AG
Table 2020-2025 Bioeq AG Anti-VEGF Drugs Revenue Gross Profit Margin
Figure 2020-2025 Bioeq AG Anti-VEGF Drugs Revenue and Growth Rate
Figure 2020-2025 Bioeq AG Anti-VEGF Drugs Market Share
......
